MiR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. (1st June 2017)
- Record Type:
- Journal Article
- Title:
- MiR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. (1st June 2017)
- Main Title:
- MiR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis
- Authors:
- El Bezawy, Rihan
Cominetti, Denis
Fenderico, Nicola
Zuco, Valentina
Beretta, Giovanni Luca
Dugo, Matteo
Arrighetti, Noemi
Stucchi, Claudio
Rancati, Tiziana
Valdagni, Riccardo
Zaffaroni, Nadia
Gandellini, Paolo - Abstract:
- Abstract: Radiotherapy is one of the main treatment choices for non-metastatic prostate cancer (PCa), although development of radioresistance limits its effectiveness. Mounting evidence supports the ability of microRNAs to interfere with different radioresistance-associated pathways, suggesting their potential as radiosensitizers. Here, we demonstrate that reconstitution of miR-875-5p, whose expression is down-regulated in PCa clinical samples and directly correlates with that of E-cadherin, was able to enhance radiation response in PCa cell lines and xenografts through EGFR direct targeting. Consistent with the established role of EGFR in sustaining epithelial-to-mesenchymal transition (EMT) and promoting DNA repair following radiation-induced nuclear translocation, we found that miR-875-5p reconstitution in PCa cells counteracted EMT and impaired DNA lesion clearance. Down-regulation of the EMT-inducing transcription factor ZEB1, which also plays a role in homologous recombination-mediated repair of DNA lesions by regulating CHK1 expression, was found to be a major determinant of miR-875-5p -induced radiosensitization, as confirmed by phenocopy experiments showing that siRNA-mediated ZEB1 knock-down was able to reproduce the microRNA radiosensitizing effect. Overall, our data support the clinical interest in developing a novel therapeutic approach based on miR-875-5p reconstitution to increase PCa response to radiotherapy. Highlights: miR-875-5p expression isAbstract: Radiotherapy is one of the main treatment choices for non-metastatic prostate cancer (PCa), although development of radioresistance limits its effectiveness. Mounting evidence supports the ability of microRNAs to interfere with different radioresistance-associated pathways, suggesting their potential as radiosensitizers. Here, we demonstrate that reconstitution of miR-875-5p, whose expression is down-regulated in PCa clinical samples and directly correlates with that of E-cadherin, was able to enhance radiation response in PCa cell lines and xenografts through EGFR direct targeting. Consistent with the established role of EGFR in sustaining epithelial-to-mesenchymal transition (EMT) and promoting DNA repair following radiation-induced nuclear translocation, we found that miR-875-5p reconstitution in PCa cells counteracted EMT and impaired DNA lesion clearance. Down-regulation of the EMT-inducing transcription factor ZEB1, which also plays a role in homologous recombination-mediated repair of DNA lesions by regulating CHK1 expression, was found to be a major determinant of miR-875-5p -induced radiosensitization, as confirmed by phenocopy experiments showing that siRNA-mediated ZEB1 knock-down was able to reproduce the microRNA radiosensitizing effect. Overall, our data support the clinical interest in developing a novel therapeutic approach based on miR-875-5p reconstitution to increase PCa response to radiotherapy. Highlights: miR-875-5p expression is down-regulated in prostate cancer clinical samples. miR-875-5p reconstitution enhances radiation response in prostate cancer models through EGFR direct targeting. Radiosensitization relies on EMT suppression and DNA repair inhibition as a consequence of ZEB1 down-regulation. … (more)
- Is Part Of:
- Cancer letters. Volume 395(2017)
- Journal:
- Cancer letters
- Issue:
- Volume 395(2017)
- Issue Display:
- Volume 395, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 395
- Issue:
- 2017
- Issue Sort Value:
- 2017-0395-2017-0000
- Page Start:
- 53
- Page End:
- 62
- Publication Date:
- 2017-06-01
- Subjects:
- microRNAs -- Prostate cancer -- Radiosensitivity -- EMT -- EGFR
CHK1 Checkpoint kinase 1 -- EGFR Epidermal growth factor receptor -- EMT Epithelial-to-mesenchymal transition -- HR Homologous recombination -- LIN7C Lin-7 homolog C -- miRNA microRNA -- NHEJ Non homologous end joining -- PCa Prostate cancer -- qRT-PCR Quantitative real-time polymerase chain reaction -- SCID Severe combined immunodeficiency -- siRNA Small interfering RNA -- ZEB1 Zinc finger E-box binding homeobox 1
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2017.02.033 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2639.xml